Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
Arshpreet Kaur, Jeremy Baldwin, Deshkanwar Singh Brar, Deepak B. Salunke, Nikolai Petrovsky
Topics & Concepts
Vaccine adjuvantToll-like receptorTollCancerReceptorAdjuvantComputational biologyMedicineAgonistBiologyImmunologyPharmacologyImmune systemInnate immune systemInternal medicineImmune Response and InflammationImmunotherapy and Immune ResponsesInfluenza Virus Research Studies